Chronic Primary Immune Thrombocytopenia clinical trials

Explore recruiting chronic primary immune thrombocytopenia clinical trials.

Recruiting chronic primary immune thrombocytopenia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Chronic Primary Immune Thrombocytopenia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Open-label, Multicenter Continuation Trial to Evaluate the Long-term Safety and Efficacy of Mezagitamab Subcutaneous Injection in Adults with Chronic Primary Immune Thrombocytopenia

Bulgaria, Spain, Netherlands, Italy, Poland, Greece +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy and Safety of Mezagitamab Subcutaneous Injection in Participants with Chronic Primary Immune Thrombocytopenia

Poland, Spain, Bulgaria, Italy, Netherlands, Croatia +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Chronic Primary Immune Thrombocytopenia trials by city

Chronic Primary Immune Thrombocytopenia in Toronto Chronic Primary Immune Thrombocytopenia in Vancouver Chronic Primary Immune Thrombocytopenia in Montreal Chronic Primary Immune Thrombocytopenia in Calgary Chronic Primary Immune Thrombocytopenia in Edmonton Chronic Primary Immune Thrombocytopenia in Ottawa Chronic Primary Immune Thrombocytopenia in Winnipeg Chronic Primary Immune Thrombocytopenia in Quebec City Chronic Primary Immune Thrombocytopenia in Hamilton Chronic Primary Immune Thrombocytopenia in Kitchener Chronic Primary Immune Thrombocytopenia in London Chronic Primary Immune Thrombocytopenia in Halifax Chronic Primary Immune Thrombocytopenia in New York Chronic Primary Immune Thrombocytopenia in Los Angeles Chronic Primary Immune Thrombocytopenia in Chicago Chronic Primary Immune Thrombocytopenia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease